Sector Chart Unicycive Therapeutics, Inc.

Stocks

UNCY

US90466Y2028

Biotechnology & Medical Research

Real-time Estimate Cboe BZX 15:19:25 2026-09-01 EDT			5-day change	1st Jan Change
5.090 ^USD	-2.12%		-7.31%	-12.13%

08-13	B. Riley Adjusts Price Target on Unicycive Therapeutics to $20 From $22, Maintains Buy Rating	MT
08-12	Unicycive Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
UNICYCIVE THERAPEUTICS, INC.	145M	-	-	-	-	-
WUXI APPTEC CO., LTD.	68.13B
ARGENX SE	63.6B
WUXI BIOLOGICS (CAYMAN) INC.	25.57B
INSMED INCORPORATED	26.6B					-
BIONTECH SE	25.52B					-